Fluticasone furoate, umeclidinium and vilanterol dry powder triple therapy inhaler

Description

In this Product Explainer, Respiratory Physician Dr Kwok Yan explains the role of fluticasone furoate, umeclidinium and vilanterol dry powder triple therapy inhaler for the maintenance treatment of asthma in adult patients who are not adequately controlled with an ICS+LABA (7 mins).

This educational activity was developed by Healthed at the request of and with funding from GSK.

PM-AU-FVU-OGM-220003 approved June 2022

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Dr Rebecca Moore

Dr Rebecca Moore

Cognitive Assessment Tools – A Practical Guide: Which Option for Whom

Dr David Lim & Prof Richard Harvey

Dr David Lim & Prof Richard Harvey

Fireside Discussion – Chronic Sinusitis & Nasal Polys Management Update

A/Prof Michelle Rodrigues

A/Prof Michelle Rodrigues

Acne Scarring

Dr Mitchell Creinin MD

Dr Mitchell Creinin MD

Natural Estrogen, Contraception and Clot Risk

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Dr Kwok Yan

expert

Dr Kwok Yan

Respiratory Physician

Date published: 14 June 2022